Post-approval studies (Phase 4)Study completedNCT02726009
What this trial is testing
A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer
Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 230